Psoriatic Arthritis

The US Food and Drug Administration has approved the drug based on the results from the KEEPsAKE-1 and KEEPsAKE-2 randomized, placebo-controlled studies.

New research reveals psoriatic arthritis manifestations vary according to patient sex.

Psoriatic diseases may increase risk of maternal complications in pregnant patients.

Researchers sought to determine the best methodology for identifying psoriatic arthritis among patients with musculoskeletal symptoms.

Past studies have shown that psoriatic arthritis negatively affects patients’ psychosocial aspects of health and quality of life. New research unveils whether these features are present before diagnosis and...

While early diagnosis of psoriatic arthritis is key, a new study that was released during ACR Convergence shows that there is often a delay in diagnosis. Find out which patients are at the highest risk for...

Patients with psoriatic arthritis commonly experience fatigue. To better understand this association, researchers evaluated fatigue and its relationship with disease parameters, functional disability,...

A new scoring system has been developed to assist in diagnosing and managing a common feature of psoriatic arthritis.

Patients with psoriatic arthritis have longer duration of disease and take higher doses of glucocorticoids than patients with rheumatic arthritis. What does new research show about the relative bone mineral...

Because scarce data exists on long-term treatment with biologic therapies in patients with psoriatic arthritis, the researchers in the FUTURE 2 study aimed to assess the 5-year results on the efficacy and...